Blair v. Takeda Pharmaceuticals USA, Inc. et al
| Anderson Blair |
| Abbott Laboratories, Takeda Pharmaceuticals USA, Inc., Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., TAP Pharmaceutical Products, Inc. f/k/a TAP Holdings, Inc., Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals America, Inc. |
| 1:2020cv07580 |
| December 18, 2020 |
| US District Court for the Northern District of Illinois |
| Virginia M Kendall |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. ยง 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 6, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| ELECTRONIC Acknowledgement of case transferred to the District of New Jersey [LIVE] as case 2:21-cv-00227, filed 01/06/2021. (bg, ) |
| Filing 9 TRANSFERRED to the District of New Jersey, Newark Division, the electronic record. (aee, ) |
| Filing 8 CONDITIONAL TRANSFER ORDER from MDL Panel transferring case to District of New Jersey, Newark Division. (aee, ) |
| Civil Case Terminated pursuant to MDL (2789) Conditional Transfer Order filed 01/04/2021. (aee, ) |
| Filing 7 MAILED Notice of Removal letter to counsel of record. (aee, ) |
| Filing 6 MINUTE entry before the Honorable Virginia M. Kendall. Initial status hearing set for 1/25/2021 at 9:00 a.m. which will proceed via Teleconference. Joint Status Report due by 1/20/2021. The parties are directed to Judge Kendall's web page found at www.ilnd.uscourts.gov for information about the Initial Status Report and for information regarding all standing orders for cases on Judge Kendall's docket. The parties shall follow all of the standing orders for Judge Kendall and all Local Rules which can be found at the same web page. For the Initial Status Report, the parties are to report on the following: (1) Possibility of settlement in the case; (2) if no possibility of settlement exists, the nature and length of discovery necessary (with specific dates) to get the case ready for trial; 3) whether the parties jointly consent to proceed before the Magistrate Judge. At the Initial Status Hearing, the Parties shall be prepared to inform the Court about the extent of monetary damages in order for the Court to address the proportionality of discovery as required by Fed. R. Civ. P. 26. Lead counsel is directed to appear at this status hearing. Teleconference instructions are as follows: Prior to the conference call, Please click on this hyper link: https://teleconference.uc.att.com/ecm/?bp=4044432170&mac=2413900 to take you to Judge Kendall's telephone conference login. From there, join conference As Guest, ENTER YOUR NAME, Type the digits in the picture, Click on the Call Me option and fill in your phone number (no hypens) and NAME. If you do not have access to a computer Dial: (877)848-7030, the access code is: 2413900#. Given the increased volume of users that is anticipated, we ask that you keep your phone on mute until your case is called. Please also remember to SAY YOUR NAME EACH AND EVERY TIME BEFORE YOU SPEAK. The Court prefers that you use the procedure that requires that the system calls your phone and you enter your name so that the Court and the Court reporter can see who is speaking during the hearing. Mailed notice (lk, ) |
| CASE ASSIGNED to the Honorable Virginia M. Kendall. Designated as Magistrate Judge the Honorable Gabriel A. Fuentes. Case assignment: Random assignment. (exr, ) |
| Filing 5 ATTORNEY Appearance for Defendants Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. by Sherry Ann Knutson (Knutson, Sherry) |
| Filing 4 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. (Hemmings, James) |
| Filing 3 ATTORNEY Appearance for Defendants Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. by James R M Hemmings (Hemmings, James) |
| Filing 2 CIVIL Cover Sheet (Hemmings, James) |
| Filing 1 NOTICE of Removal from Circuit Court of Cook County, Illinois, case number (2019-L-005942) filed by Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals USA, Inc. Filing fee $ 402, receipt number 0752-17761256. (Attachments: #1 Exhibit A, #2 Exhibit B)(Hemmings, James) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
